A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Clinical trial NCT01307267 · COMPLETED

Trial details

NCT number: NCT01307267
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Squamous Cell of Head and Neck Malignant Melanoma

Start date: 2011-06-21
Primary completion: 2019-02-20
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.